Literature DB >> 31774948

Monoclonal Antibody Therapy for Ebola Virus Disease.

Myron M Levine1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31774948     DOI: 10.1056/NEJMe1915350

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  22 in total

1.  Pan-ebolavirus protective therapy by two multifunctional human antibodies.

Authors:  Pavlo Gilchuk; Charles D Murin; Robert W Cross; Philipp A Ilinykh; Kai Huang; Natalia Kuzmina; Viktoriya Borisevich; Krystle N Agans; Joan B Geisbert; Seth J Zost; Rachel S Nargi; Rachel E Sutton; Naveenchandra Suryadevara; Robin G Bombardi; Robert H Carnahan; Alexander Bukreyev; Thomas W Geisbert; Andrew B Ward; James E Crowe
Journal:  Cell       Date:  2021-10-28       Impact factor: 41.582

2.  Molecular Communications in Viral Infections Research: Modeling, Experimental Data, and Future Directions.

Authors:  Michael Taynnan Barros; Mladen Veletic; Masamitsu Kanada; Massimiliano Pierobon; Seppo Vainio; Ilangko Balasingham; Sasitharan Balasubramaniam
Journal:  IEEE Trans Mol Biol Multiscale Commun       Date:  2021-04-15

3.  Optimization of a mAb production process with regard to robustness and product quality using quality by design principles.

Authors:  Ole Jacob Wohlenberg; Carlotta Kortmann; Katharina V Meyer; Jana Schellenberg; Katharina Dahlmann; Janina Bahnemann; Thomas Scheper; Dörte Solle
Journal:  Eng Life Sci       Date:  2022-06-03       Impact factor: 3.405

4.  Risk factors for Ebola virus disease among household care providers, Sierra Leone, 2015.

Authors:  Nadezhda Duffy; Dana Bruden; Harold Thomas; Erin Nichols; Barbara Knust; Thomas Hennessy; Mary R Reichler
Journal:  Int J Epidemiol       Date:  2022-10-13       Impact factor: 9.685

5.  Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody.

Authors:  Dora Pinto; Young-Jun Park; Martina Beltramello; Alexandra C Walls; M Alejandra Tortorici; Siro Bianchi; Stefano Jaconi; Katja Culap; Fabrizia Zatta; Anna De Marco; Alessia Peter; Barbara Guarino; Roberto Spreafico; Elisabetta Cameroni; James Brett Case; Rita E Chen; Colin Havenar-Daughton; Gyorgy Snell; Amalio Telenti; Herbert W Virgin; Antonio Lanzavecchia; Michael S Diamond; Katja Fink; David Veesler; Davide Corti
Journal:  Nature       Date:  2020-05-18       Impact factor: 49.962

Review 6.  Drug combination therapy for emerging viral diseases.

Authors:  Zeenat A Shyr; Yu-Shan Cheng; Donald C Lo; Wei Zheng
Journal:  Drug Discov Today       Date:  2021-05-21       Impact factor: 7.851

7.  A Potently Neutralizing Antibody Protects Mice against SARS-CoV-2 Infection.

Authors:  Wafaa B Alsoussi; Jackson S Turner; James B Case; Haiyan Zhao; Aaron J Schmitz; Julian Q Zhou; Rita E Chen; Tingting Lei; Amena A Rizk; Katherine M McIntire; Emma S Winkler; Julie M Fox; Natasha M Kafai; Larissa B Thackray; Ahmed O Hassan; Fatima Amanat; Florian Krammer; Corey T Watson; Steven H Kleinstein; Daved H Fremont; Michael S Diamond; Ali H Ellebedy
Journal:  J Immunol       Date:  2020-06-26       Impact factor: 5.426

Review 8.  Immunology of COVID-19: Current State of the Science.

Authors:  Nicolas Vabret; Graham J Britton; Conor Gruber; Samarth Hegde; Joel Kim; Maria Kuksin; Rachel Levantovsky; Louise Malle; Alvaro Moreira; Matthew D Park; Luisanna Pia; Emma Risson; Miriam Saffern; Bérengère Salomé; Myvizhi Esai Selvan; Matthew P Spindler; Jessica Tan; Verena van der Heide; Jill K Gregory; Konstantina Alexandropoulos; Nina Bhardwaj; Brian D Brown; Benjamin Greenbaum; Zeynep H Gümüş; Dirk Homann; Amir Horowitz; Alice O Kamphorst; Maria A Curotto de Lafaille; Saurabh Mehandru; Miriam Merad; Robert M Samstein
Journal:  Immunity       Date:  2020-05-06       Impact factor: 31.745

9.  Neutralizing Monoclonal Antibodies against the Gn and the Gc of the Andes Virus Glycoprotein Spike Complex Protect from Virus Challenge in a Preclinical Hamster Model.

Authors:  James Duehr; Meagan McMahon; Brandi Williamson; Fatima Amanat; Alan Durbin; David W Hawman; Danny Noack; Skyler Uhl; Gene S Tan; Heinz Feldmann; Florian Krammer
Journal:  mBio       Date:  2020-03-24       Impact factor: 7.867

10.  Proteo-Genomic Analysis Identifies Two Major Sites of Vulnerability on Ebolavirus Glycoprotein for Neutralizing Antibodies in Convalescent Human Plasma.

Authors:  Pavlo Gilchuk; Adrian Guthals; Stefano R Bonissone; Jared B Shaw; Philipp A Ilinykh; Kai Huang; Robin G Bombardi; Jenny Liang; Ariadna Grinyo; Edgar Davidson; Elaine C Chen; Bronwyn M Gunn; Galit Alter; Erica Ollmann Saphire; Benjamin J Doranz; Alexander Bukreyev; Larry Zeitlin; Natalie Castellana; James E Crowe
Journal:  Front Immunol       Date:  2021-07-16       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.